Targeting metabolic changes in cancer: novel therapeutic approaches

Area of Science:

• Oncology
• Cancer Metabolism
• Drug Discovery

Background:

• Targeting cancer metabolism is a key research area.
• Antimetabolites represent an early successful strategy in cancer therapy.
• Existing antimetabolite approaches can be improved.

Purpose of the Study:

• To review advanced therapeutic strategies targeting cancer metabolism.
• To highlight novel metabolic drug targets and their potential.
• To discuss approaches leveraging genetic anchors and tumor-specific metabolic dependencies.

Main Methods:

• Literature review of current and emerging cancer metabolism therapies.
• Analysis of strategies improving on antimetabolite approaches.
• Identification of new metabolic targets based on genetic and systems biology insights.

Main Results:

• Several novel metabolic drug targets are identified.
• Targets with strong genetic anchors (e.g., isocitrate dehydrogenase 1/2, Enolase 2) facilitate patient selection.
• Hypothesis-driven and systems biology approaches reveal exploitable tumor metabolic dependencies (e.g., fatty acid oxidation, NAD+ synthesis, glutamine metabolism).

Conclusions:

• Advances in targeting cancer metabolism offer promising therapeutic avenues.
• Combining genetic insights with systems biology enhances the development of novel metabolic drugs.
• Exploiting specific tumor metabolic vulnerabilities is a viable strategy for cancer treatment.